Clinical Scorecard: Distinguishing Autoreactivity from Autoimmunity: Features of CD4 T-cells Specific to Autoantigens in Rheumatoid Arthritis and Healthy Individuals.
At a Glance
Category
Detail
Condition
Rheumatoid Arthritis
Key Mechanisms
CD4 T cells specific for citrullinated peptides play a role in RA immunopathogenesis.
Target Population
Individuals with Rheumatoid Arthritis and Healthy Controls.
Care Setting
Translational and Clinical Research.
Key Highlights
Characterization of autoreactive CD4 T cells in RA and healthy individuals.
Assessment of autoreactive T cell frequency and phenotype.
Focus on memory CD4 T cell compartment.
Study includes HLA-DRB1 04:01 positive individuals.
No significant difference in autoreactive T cell frequency between groups.
Guideline-Based Recommendations
Diagnosis
Characterize CD4 T cells specific for citrullinated peptides.
Management
Utilize immune state biomarkers for RA treatment development.
Monitoring & Follow-up
Assess autoreactive T cell frequency and phenotype over disease stages.
Risks
Potential for misinterpretation of autoreactivity versus autoimmunity.
Patient & Prescribing Data
RA patients at different disease stages and healthy controls.
Study includes patients pre-treatment and on treatment.
Clinical Best Practices
Employ MHC II-peptide tetramers for T cell assessment.
Utilize spectral flow cytometry for detailed analysis.
by James A. Stanway, Daniel Peters, Helen Waller, Jeremy Lakey, Henrique De Paula Lemos, Kristian Williams, Abbie Degnan, Julie Diboll, Abdul Mannan Baru, David Tough, Arthur G. Pratt, Catharien M.U. Hilkens, Amy E. Anderson, John D. Isaacs
